Published in Urology on December 29, 2009
Direct Full-stage Implantation of Sacral Neuromodulation | NCT03697954
Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology. Am J Physiol Regul Integr Comp Physiol (2014) 1.76
Urinary Incontinence Before and After Bariatric Surgery. JAMA Intern Med (2015) 1.47
The effect of pelvic organ prolapse severity on improvement in overactive bladder symptoms after pelvic reconstructive surgery. Int Urogynecol J (2012) 0.92
Pelvic floor disorders following vaginal or cesarean delivery. Curr Opin Obstet Gynecol (2012) 0.89
The association of adiposity and overactive bladder appears to differ by gender: results from the Boston Area Community Health survey. J Urol (2011) 0.89
Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care. Curr Urol Rep (2012) 0.89
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder. Int Urogynecol J (2014) 0.87
Altered detrusor gap junction communications induce storage symptoms in bladder inflammation: a mouse cyclophosphamide-induced model of cystitis. PLoS One (2014) 0.84
Does central sensitization help explain idiopathic overactive bladder? Nat Rev Urol (2016) 0.82
Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity. BMC Neurol (2014) 0.82
Control of urinary bladder smooth muscle excitability by the TRPM4 channel modulator 9-phenanthrol. Channels (Austin) (2013) 0.81
A healthy bladder: a consensus statement. Int J Clin Pract (2011) 0.81
The Burden of Overactive Bladder on US Public Health. Curr Bladder Dysfunct Rep (2016) 0.81
Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module. Health Qual Life Outcomes (2014) 0.79
Overactive bladder. F1000Res (2015) 0.79
Hypnotherapy for treatment of overactive bladder: a randomized controlled trial pilot study. Female Pelvic Med Reconstr Surg (2011) 0.77
Defining and managing overactive bladder: disagreement among the experts. Urology (2013) 0.77
Overactive Bladder Is Strongly Associated With Frailty in Older Individuals. Urology (2017) 0.77
An update on the use of transdermal oxybutynin in the management of overactive bladder disorder. Ther Adv Urol (2016) 0.75
Clinical pharmacology of functional disorders of the urogenital system. Br J Clin Pharmacol (2011) 0.75
Editorial comment. Urology (2010) 0.75
Role of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladder. Turk J Urol (2015) 0.75
Potential benefits of diagnosis and treatment on health outcomes among elderly people with symptoms of overactive bladder. Int J Clin Pract (2015) 0.75
Editorial comment. Urology (2010) 0.75
Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder? Drug Des Devel Ther (2014) 0.75
Antimuscarinic Agent Treatment Affecting Patient-Reported Outcomes in Overactive Bladder Syndrome With Depressive Symptoms. Int Neurourol J (2016) 0.75
De novo overactive bladder following midurethral sling procedures: a systematic review of the literature and meta-analysis. Int Urogynecol J (2017) 0.75
Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls. Int Urogynecol J (2012) 0.75
Effect of sacrocolpopexy and retropubic sling on overactive bladder symptoms. J Turk Ger Gynecol Assoc (2017) 0.75
Time-to-effect with darifenacin in overactive bladder: a pooled analysis. Int Urogynecol J (2011) 0.75
Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA (2011) 7.61
Marital status and survival in patients with cancer. J Clin Oncol (2013) 5.82
The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics (2003) 4.99
Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol (2008) 4.75
Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol (2011) 4.60
Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol (2008) 4.23
Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol (2003) 4.11
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer (2007) 3.92
Use, costs and comparative effectiveness of robotic assisted, laparoscopic and open urological surgery. J Urol (2012) 2.94
Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. J Clin Oncol (2005) 2.87
Hospital volume, utilization, costs and outcomes of robot-assisted laparoscopic radical prostatectomy. J Urol (2012) 2.79
Comparative effectiveness of perineal versus retropubic and minimally invasive radical prostatectomy. J Urol (2010) 2.77
Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther (2006) 2.73
Delivering high-quality and affordable care throughout the cancer care continuum. J Clin Oncol (2013) 2.39
Influence of surgeon and hospital volume on radical prostatectomy costs. J Urol (2012) 2.37
Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s). Urology (2010) 2.31
Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Urology (2011) 2.24
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach. J Urol (2012) 2.22
Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation. BJU Int (2013) 2.12
Stepwise approach for nerve sparing without countertraction during robot-assisted radical prostatectomy: technique and outcomes. Eur Urol (2011) 2.09
Comparison of outpatient narcotic prescribing patterns after minimally invasive versus retropubic and perineal radical prostatectomy. J Urol (2011) 2.05
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology (2013) 2.04
Outcomes of vaginal prolapse surgery among female Medicare beneficiaries: the role of apical support. Obstet Gynecol (2013) 1.88
Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Eur Urol (2012) 1.86
Utilization and expense of adjuvant cancer therapies following radical prostatectomy. Cancer (2011) 1.85
Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy. Urology (2010) 1.83
Correlates of bother following treatment for clinically localized prostate cancer. J Urol (2010) 1.82
Factors associated with the adoption of minimally invasive radical prostatectomy in the United States. J Urol (2012) 1.78
Temporal national trends of minimally invasive and retropubic radical prostatectomy outcomes from 2003 to 2007: results from the 100% Medicare sample. Eur Urol (2011) 1.76
Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol (2014) 1.74
Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007. BJU Int (2013) 1.73
Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite. Cancer (2008) 1.71
Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer (2004) 1.64
Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes. Urology (2013) 1.63
Athermal division and selective suture ligation of the dorsal vein complex during robot-assisted laparoscopic radical prostatectomy: description of technique and outcomes. Eur Urol (2010) 1.58
Trends in the care of radical prostatectomy in the United States from 2003 to 2006. BJU Int (2010) 1.57
Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation (2008) 1.56
Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface (2006) 1.53
Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin (2004) 1.50
Trends in the surgical management of stress urinary incontinence among female Medicare beneficiaries, 2002-2007. Urology (2013) 1.49
Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes (2004) 1.48
A systematic review of the volume-outcome relationship for radical prostatectomy. Eur Urol (2013) 1.48
Pretreatment expectations of patients undergoing robotic assisted laparoscopic or open retropubic radical prostatectomy. J Urol (2012) 1.47
Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy. J Urol (2003) 1.47
The effect of concomitant prolapse repair on sling outcomes. J Urol (2008) 1.47
Technical refinement and learning curve for attenuating neurapraxia during robotic-assisted radical prostatectomy to improve sexual function. Eur Urol (2012) 1.45
Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size. Int J Radiat Oncol Biol Phys (2010) 1.44
Economic burden of endometriosis. Fertil Steril (2006) 1.43
Complications of sling surgery among female Medicare beneficiaries. Obstet Gynecol (2007) 1.41
Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer (2014) 1.41
2008 US Preventive Services Task Force recommendations and prostate cancer screening rates. JAMA (2012) 1.41
Thromboembolic complications of sling surgery for stress urinary incontinence among female Medicare beneficiaries. Urology (2009) 1.41
Testosterone replacement therapy in men with prostate cancer: a time-varying analysis. J Sex Med (2014) 1.39
Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus. Pharmacotherapy (2007) 1.38
Randomized controlled trial of barbed polyglyconate versus polyglactin suture for robot-assisted laparoscopic prostatectomy anastomosis: technique and outcomes. Eur Urol (2010) 1.38
Effects of the ritonavir price increase on the cost of protease inhibitor regimens in United States. Manag Care Interface (2006) 1.38
Direct treatment cost of atrial fibrillation in the elderly American population: a Medicare perspective. J Med Econ (2008) 1.35
The effect of age on outcomes of sling surgery for urinary incontinence. J Am Geriatr Soc (2007) 1.34
Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials. J Urol (2010) 1.29
National trends in the usage and success of sacral nerve test stimulation. J Urol (2011) 1.27
Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res (2006) 1.23
Misconceptions and miscommunication among aging women with overactive bladder symptoms. Urology (2010) 1.20
The role of provider volume on outcomes after sling surgery for stress urinary incontinence. J Urol (2007) 1.18
Practice variation in the surgical management of urinary lithiasis. J Urol (2011) 1.16
Long-term cost of stroke subtypes among Medicare beneficiaries. Cerebrovasc Dis (2006) 1.14
Overuse of imaging for staging low risk prostate cancer. J Urol (2011) 1.14
The financial burden of stress urinary incontinence among women in the United States. Curr Urol Rep (2011) 1.13
Economic burden of acute myeloid leukemia: a literature review. Cancer Treat Rev (2004) 1.12
Variations in stress incontinence and prolapse management by surgeon specialty. J Urol (2007) 1.12
Patterns of pessary care and outcomes for medicare beneficiaries with pelvic organ prolapse. Female Pelvic Med Reconstr Surg (2013) 1.09
Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev (2004) 1.06
Chronic lymphocytic leukemia: economic burden and quality of life: literature review. Am J Ther (2005) 1.06
Determinants of treatment regret in low-income, uninsured men with prostate cancer. Urology (2008) 1.05
Variations in use of imaging in a national sample of men with early-stage prostate cancer. Urology (2002) 1.04
Anatomic bladder neck preservation during robotic-assisted laparoscopic radical prostatectomy: description of technique and outcomes. Eur Urol (2009) 1.03
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int (2011) 1.03
Overcoming the learning curve for robotic-assisted laparoscopic radical prostatectomy. Urol Clin North Am (2010) 1.03
Utilization of pharmacotherapy for erectile dysfunction following treatment for prostate cancer. J Sex Med (2010) 1.02
Economic burden of head and neck cancer. A literature review. Eur J Health Econ (2004) 1.01
Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction. Int J Radiat Oncol Biol Phys (2011) 1.00
Colorectal cancer screening attitudes and practices in the general population: a risk-adjusted survey. J Public Health Manag Pract (2005) 1.00
Ethnicity and variations of pelvic organ prolapse bother. Int Urogynecol J (2013) 1.00
Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol (2012) 0.98
Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States. Cancer (2011) 0.97
Material characterization of ex vivo prostate tissue via spherical indentation in the clinic. Med Eng Phys (2010) 0.97
Medicare payments, healthcare service use, and telemedicine implementation costs in a randomized trial comparing telemedicine case management with usual care in medically underserved participants with diabetes mellitus (IDEATel). J Am Med Inform Assoc (2010) 0.97
Morbidity and mortality among elderly Americans with different stroke subtypes. Adv Ther (2007) 0.96
Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health (2003) 0.95
The role of preoperative testing on outcomes after sling surgery for stress urinary incontinence. J Urol (2007) 0.93
Surgical apgar outcome score: perioperative risk assessment for radical cystectomy. J Urol (2009) 0.93
Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model. CNS Drugs (2007) 0.93
A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice. J Womens Health (Larchmt) (2008) 0.93
Validation of a quality-of-life instrument for laryngopharyngeal reflux. Arch Otolaryngol Head Neck Surg (2005) 0.92
Correlates of urinary incontinence in community-dwelling older Latinos. J Am Geriatr Soc (2010) 0.92
Population-based determinants of radical prostatectomy surgical margin positivity. BJU Int (2010) 0.91